Osimertinib Real World Toxicity Substantially Less than 1st Gen TKIs - 102262

Spotlight
Video

Osimertinib Real World Toxicity Substantially Less than 1st Gen TKIs

Loading........
Description: Charles Rudin, MD, PhD of Memorial Sloan Kettering Cancer Center discusses Osimertinib and the real world toxicity issues including that it's substantially less than 1st generationg TKIs from the 22nd Annual Perspectives in Thoracic Oncology in New York http://imedex.com/perspecti...
Shared By : thoraciconcology
Posted on : 12/29/17
Added : 22 days ago



Recommended

Nothing found.

More From thoraciconcology

Nothing found.